Literature DB >> 16079393

Prenylation-defective human connexin32 mutants are normally localized and function equivalently to wild-type connexin32 in myelinating Schwann cells.

Yan Huang1, Erich E Sirkowski, John T Stickney, Steven S Scherer.   

Abstract

Mutations in GJB1, the gene encoding the gap junction protein connexin32 (Cx32), cause the X-linked form of Charcot-Marie-Tooth disease, an inherited demyelinating neuropathy. The C terminus of human Cx32 contains a putative prenylation motif that is conserved in Cx32 orthologs. Using [3H]mevalonolactone ([3H]MVA) incorporation, we demonstrated that wild-type human connexin32 can be prenylated in COS7 cells, in contrast to disease-associated mutations that are predicted to disrupt the prenylation motif. We generated transgenic mice that express these mutants in myelinating Schwann cells. Male mice expressing a transgene were crossed with female Gjb1-null mice; the male offspring were all Gjb1-null, and one-half were transgene positive; in these mice, all Cx32 was derived from expression of the transgene. The mutant human protein was properly localized in myelinating Schwann cells in multiple transgenic lines and did not alter the localization of other components of paranodes and incisures. Finally, both the C280G and the S281x mutants appeared to "rescue" the phenotype of Gjb1-null mice, because transgene-positive male mice had significantly fewer abnormally myelinated axons than did their transgene-negative male littermates. These results indicate that Cx32 is prenylated, but that prenylation is not required for proper trafficking of Cx32 and perhaps not even for certain aspects of its function, in myelinating Schwann cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16079393      PMCID: PMC6725241          DOI: 10.1523/JNEUROSCI.1319-05.2005

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  15 in total

1.  The role of gap junctions in Charcot-Marie-Tooth disease.

Authors:  Kleopas A Kleopa
Journal:  J Neurosci       Date:  2011-12-07       Impact factor: 6.167

Review 2.  Life cycle of connexins in health and disease.

Authors:  Dale W Laird
Journal:  Biochem J       Date:  2006-03-15       Impact factor: 3.857

Review 3.  Gap junctions couple astrocytes and oligodendrocytes.

Authors:  Jennifer L Orthmann-Murphy; Charles K Abrams; Steven S Scherer
Journal:  J Mol Neurosci       Date:  2008-05       Impact factor: 3.444

Review 4.  Gap junctions in inherited human disorders of the central nervous system.

Authors:  Charles K Abrams; Steven S Scherer
Journal:  Biochim Biophys Acta       Date:  2011-08-16

Review 5.  Molecular genetics of X-linked Charcot-Marie-Tooth disease.

Authors:  Kleopas A Kleopa; Steven S Scherer
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 6.  X-linked Charcot-Marie-Tooth disease.

Authors:  Steven S Scherer; Kleopas A Kleopa
Journal:  J Peripher Nerv Syst       Date:  2012-12       Impact factor: 3.494

7.  Characterization of the structure and intermolecular interactions between the connexin 32 carboxyl-terminal domain and the protein partners synapse-associated protein 97 and calmodulin.

Authors:  Kelly Stauch; Fabien Kieken; Paul Sorgen
Journal:  J Biol Chem       Date:  2012-06-20       Impact factor: 5.157

8.  Cx29 and Cx32, two connexins expressed by myelinating glia, do not interact and are functionally distinct.

Authors:  Meejin Ahn; Jonathan Lee; Andreas Gustafsson; Alan Enriquez; Eric Lancaster; Jai-Yoon Sul; Philip G Haydon; David L Paul; Yan Huang; Charles K Abrams; Steven S Scherer
Journal:  J Neurosci Res       Date:  2008-04       Impact factor: 4.164

9.  Ablation of Cx47 in transgenic mice leads to the loss of MUPP1, ZONAB and multiple connexins at oligodendrocyte-astrocyte gap junctions.

Authors:  Xinbo Li; M Penes; B Odermatt; K Willecke; J I Nagy
Journal:  Eur J Neurosci       Date:  2008-10       Impact factor: 3.386

10.  Connexin32 mutations cause loss of function in Schwann cells and oligodendrocytes leading to PNS and CNS myelination defects.

Authors:  Irene Sargiannidou; Natalie Vavlitou; Sophia Aristodemou; Andreas Hadjisavvas; Kyriacos Kyriacou; Steven S Scherer; Kleopas A Kleopa
Journal:  J Neurosci       Date:  2009-04-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.